Enveda Biosciences

Enveda Biosciences is a clinical-stage biotechnology company that leverages an AI-powered platform to decode the chemical complexity of the natural world. By combining mass spectrometry, machine learning, and advanced robotics, the company identifies and characterizes novel small-molecule drug candidates from nature, aiming to discover therapies significantly faster and more cost-effectively than traditional pharmaceutical methods. The company focuses on addressing large unmet medical needs across various therapeutic areas, including immunology, inflammation, fibrosis, obesity, and neurological conditions. With a sprawling pipeline of preclinical and clinical assets, Enveda is transforming natural product drug discovery into a programmable, high-throughput process.